Grand Challenges in Parkinson's Disease

Grand Challenges in Parkinson’s Disease
Grand Challenges in Parkinson’s Disease brings together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s disease research. The 2021 symposium will focus on the influence of genetic risk factors on cell and brain biology, including risk for Parkinson’s and the roles of organellar trafficking, lipid metabolism, the endolysosomal system and neuropathology. Speakers also will discuss how genetic factors may be leveraged for treatment with a special focus on clinical trials, drug discovery and biomarker development that target GBA1 and LRRK2.
Van Andel Institute and The Cure Parkinson’s Trust are thrilled to once again host Rallying to the Challenge, a meeting designed for and by people with Parkinson’s, advocates and care partners that delves into how the Parkinson’s community can impact and accelerate research.
Please note, the 2021 Grand Challenges in Parkinson’s Disease symposium and Rallying to the Challenge meeting will be virtual. All times listed are in the Eastern time zone. Registration is now closed. Please contact Kim Cousineau via email.
For questions or to be added to our mailing list, please contact Kim Cousineau via email.
October 6, 2021
Welcome
Session 1: LRRK2 and GBA1 in Parkinson’s Disease
Session 2: LRRK2 and GBA1 Cellular Function and Dysfunction I
Jay Van Andel award for outstanding achievement in Parkinson’s disease research keynote address
October 7, 2021
Welcome
From genetic risk to the clinic – or from peas to pills
Data collection: Concerns and opportunities – survey findings
Dr. Kevin McFarthing
Stretch and move
With thanks to the Davis Phinney Foundation
What are LRRK2 and GBA Parkinson’s: An overview
Dr. Laurie Sanders – Duke University
A personal story: Carrying LRRK2, my research-involved journey
Jessi Keavney (PD Avenger)
Stretch and move
With thanks to the Davis Phinney Foundation
The value of LRRK2 and GBA research: Why are they important therapeutic targets? What is the potential benefit to the broader Parkinson’s community?
Dr. Simon Stott – Cure Parkinson’s
The pipeline of genetic clinical trials
Dr. Richard Wyse – Cure Parkinson’s
Live Q&A
Session 3: LRRK2 and GBA1 Cellular Function and Dysfunction II
Session 4: The Role of Non-neuronal Fells
Poster Session
Event Details
This event has passed but you can relive it through photos. Check out the galleries.
Thanks to our wonderful sponsors!
Supporting Sponsors